<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37612427</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>13805</StartPage><MedlinePgn>13805</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13805</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-40879-y</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS), the most prevalent motor neuron disease characterized by its complex genetic structure, lacks a single diagnostic test capable of providing a conclusive diagnosis. In order to demonstrate the potential for genetic diagnosis and shed light on the pathogenic role of miRNAs in ALS, we developed an ALS diagnostic rule by training the model using 80% of a miRNA profiling dataset consisting of 253 ALS samples and 103 control samples. Subsequently, we validated the diagnostic rule using the remaining 20% of unseen samples. The diagnostic rule we developed includes miR-205-5p, miR-206, miR-376a-5p, miR-412-5p, miR-3927-3p, miR-4701-3p, miR-6763-5p, and miR-6801-3p. Remarkably, the rule achieved an 82% true positive rate and a 73% true negative rate when predicting the unseen samples. Furthermore, the identified miRNAs target 21 genes in the PI3K-Akt pathway and 27 genes in the ALS pathway, including notable genes such as BCL2, NEFH, and OPTN. We propose that miRNA profiling may serve as a complementary diagnostic tool to supplement the clinical presentation and aid in the early recognition of ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cheng</LastName><ForeName>Jack</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9305-0781</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, China Medical University Hospital, Taichung, 40447, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ho</LastName><ForeName>Wen-Kuang</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Bor-Tsang</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of Senior Citizen Service Management, National Taichung University of Science and Technology, Taichung City, 40343, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hsin-Ping</ForeName><Initials>HP</Initials><Identifier Source="ORCID">0000-0002-2569-3072</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Acupuncture Science, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan. hpliu@mail.cmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wei-Yong</ForeName><Initials>WY</Initials><Identifier Source="ORCID">0000-0002-8443-6180</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan. linwy@mail.cmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, China Medical University Hospital, Taichung, 40447, Taiwan. linwy@mail.cmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37612427</ArticleId><ArticleId IdType="pmc">PMC10447559</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-40879-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-40879-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76:1367&#x2013;1374. doi: 10.1001/jamaneurol.2019.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks, B. R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial" Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci.124, 96&#x2013;107 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, El Munsat TL. Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 2020;131:1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman EL, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400:1363. doi: 10.1016/S0140-6736(22)01272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01272-7</ArticleId><ArticleId IdType="pmc">PMC10089700</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465. doi: 10.1016/S1474-4422(21)00414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00414-2</ArticleId><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z-Y, et al. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinform. 2009;7:147&#x2013;154. doi: 10.1016/S1672-0229(08)60044-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1672-0229(08)60044-3</ArticleId><ArticleId IdType="pmc">PMC5054406</ArticleId><ArticleId IdType="pubmed">20172487</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AP, et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;49:107&#x2013;117. doi: 10.1016/j.nbd.2012.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.015</ArticleId><ArticleId IdType="pubmed">22975021</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice, B. et al. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics15, 243&#x2013;253 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumitha R, et al. Differential expression of microRNA-206 in the gastrocnemius and biceps brachii in response to CSF from sporadic amyotrophic lateral sclerosis patients. J. Neurol. Sci. 2014;345:254&#x2013;256. doi: 10.1016/j.jns.2014.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.07.005</ArticleId><ArticleId IdType="pubmed">25039065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley ZC, Campos-Melo D, Strong MJ. Novel miR-b2122 regulates several ALS-related RNA-binding proteins. Mol. Brain. 2017;10:1&#x2013;14. doi: 10.1186/s13041-017-0326-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0326-7</ArticleId><ArticleId IdType="pmc">PMC5625648</ArticleId><ArticleId IdType="pubmed">28969660</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V, Merico A, Angelini C. Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration. J. Neurol. Sci. 2017;380:58&#x2013;63. doi: 10.1016/j.jns.2017.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.008</ArticleId><ArticleId IdType="pmc">PMC5598142</ArticleId><ArticleId IdType="pubmed">28870590</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D, et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2019;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Dunlop RA, Stommel EW, Mehta P, Cox PA. miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis. J. Neurol. Sci. 2022;442:120396. doi: 10.1016/j.jns.2022.120396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120396</ArticleId><ArticleId IdType="pubmed">36081303</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, et al. Systematic review and meta-analysis on microRNAs in amyotrophic lateral sclerosis. Brain Res. Bull. 2023;194:83. doi: 10.1016/j.brainresbull.2023.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2023.01.005</ArticleId><ArticleId IdType="pubmed">36681253</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A, et al. Dysregulated mi RNA biogenesis downstream of cellular stress and ALS-causing mutations: A new mechanism for ALS. EMBO J. 2015;34:2633&#x2013;2651. doi: 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Magen I, et al. Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nat. Neurosci. 2021;24:1534&#x2013;1541. doi: 10.1038/s41593-021-00936-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00936-z</ArticleId><ArticleId IdType="pubmed">34711961</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T, et al. NCBI GEO: Archive for functional genomics data sets&#x2014;Update. Nucleic Acids Res. 2012;41:D991&#x2013;D995. doi: 10.1093/nar/gks1193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1193</ArticleId><ArticleId IdType="pmc">PMC3531084</ArticleId><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Liu H-P, Lin W-Y, Tsai F-J. Machine learning compensates fold-change method and highlights oxidative phosphorylation in the brain transcriptome of Alzheimer&#x2019;s disease. Sci. Rep.-UK. 2021;11:13704. doi: 10.1038/s41598-021-93085-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93085-z</ArticleId><ArticleId IdType="pmc">PMC8249453</ArticleId><ArticleId IdType="pubmed">34211065</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Liu H-P, Lin W-Y, Tsai F-J. Identification of contributing genes of Huntington&#x2019;s disease by machine learning. BMC Med. Genomics. 2020;13:1&#x2013;11. doi: 10.1186/s12920-020-00822-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-020-00822-w</ArticleId><ArticleId IdType="pmc">PMC7684976</ArticleId><ArticleId IdType="pubmed">33228685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ristoski P, Bizer C, Paulheim H. Mining the web of linked data with rapidminer. J. Web Semantics. 2015;35:142&#x2013;151. doi: 10.1016/j.websem.2015.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.websem.2015.06.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachos IS, et al. DIANA-TarBase v7.0: Indexing more than half a million experimentally supported miRNA: mRNA interactions. Nucleic Acids Res. 2015;43:D153&#x2013;D159. doi: 10.1093/nar/gku1215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1215</ArticleId><ArticleId IdType="pmc">PMC4383989</ArticleId><ArticleId IdType="pubmed">25416803</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, et al. The STRING database in 2021: Customizable protein&#x2013;protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605&#x2013;D612. doi: 10.1093/nar/gkaa1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveros, J. C. Venny. An Interactive Tool for Comparing Lists with Venn's Diagrams. (2007).</Citation></Reference><Reference><Citation>Boylan K. Familial amyotrophic lateral sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, et al. ALS genetics, mechanisms, and therapeutics: Where are we now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli, J., Mediani, L., Alberti, S. &amp; Carra, S. Seminars in Cell &amp; Developmental Biology. 183&#x2013;192 (Elsevier).</Citation><ArticleIdList><ArticleId IdType="pubmed">31254610</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, et al. CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis. Clin. Proteomics. 2020;17:1&#x2013;12. doi: 10.1186/s12014-020-09294-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-020-09294-7</ArticleId><ArticleId IdType="pmc">PMC7433176</ArticleId><ArticleId IdType="pubmed">32821252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-C, et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat. Neurosci. 2021;24:1077&#x2013;1088. doi: 10.1038/s41593-021-00859-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, et al. Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72-ALS/FTD. Proc. Natl. Acad. Sci. 2019;116:9628&#x2013;9633. doi: 10.1073/pnas.1901313116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901313116</ArticleId><ArticleId IdType="pmc">PMC6511021</ArticleId><ArticleId IdType="pubmed">31019093</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Carr&#xec; MT. Mitochondrial dysfunction in ALS. Prog. Neurobiol. 2012;97:54&#x2013;66. doi: 10.1016/j.pneurobio.2011.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.06.003</ArticleId><ArticleId IdType="pubmed">21827820</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radical Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. 2010;107:20523&#x2013;20528. doi: 10.1073/pnas.1006869107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006869107</ArticleId><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G, et al. MiR-206, a key modulator of skeletal muscle development and disease. Int. J. Biol. Sci. 2015;11:345. doi: 10.7150/ijbs.10921.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.10921</ArticleId><ArticleId IdType="pmc">PMC4323374</ArticleId><ArticleId IdType="pubmed">25678853</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J-F, et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol. 2010;190:867&#x2013;879. doi: 10.1083/jcb.200911036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200911036</ArticleId><ArticleId IdType="pmc">PMC2935565</ArticleId><ArticleId IdType="pubmed">20819939</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, et al. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene. 2012;508:35&#x2013;40. doi: 10.1016/j.gene.2012.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.07.058</ArticleId><ArticleId IdType="pubmed">22903028</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade HM, et al. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J. Neurol. Sci. 2016;368:19&#x2013;24. doi: 10.1016/j.jns.2016.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.046</ArticleId><ArticleId IdType="pubmed">27538595</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, et al. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol. Aging. 2017;55:123&#x2013;131. doi: 10.1016/j.neurobiolaging.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory PA, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008;10:593&#x2013;601. doi: 10.1038/ncb1722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1722</ArticleId><ArticleId IdType="pubmed">18376396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouillet JF, Chu T, Nelson DM, Mishima T, Sadovsky Y. MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J. 2010;24:2030&#x2013;2039. doi: 10.1096/fj.09-149724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-149724</ArticleId><ArticleId IdType="pmc">PMC2874470</ArticleId><ArticleId IdType="pubmed">20065103</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Finkelstein D, Sherr CJ. Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells. Proc. Natl. Acad. Sci. 2013;110:E1112&#x2013;E1121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607049</ArticleId><ArticleId IdType="pubmed">23487795</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene SB, Gunaratne PH, Hammond SM, Rosen JM. A putative role for microRNA-205 in mammary epithelial cell progenitors. J. Cell Sci. 2010;123:606&#x2013;618. doi: 10.1242/jcs.056812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.056812</ArticleId><ArticleId IdType="pmc">PMC2818197</ArticleId><ArticleId IdType="pubmed">20103531</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandellini P, et al. miR-205 regulates basement membrane deposition in human prostate: Implications for cancer development. Cell Death Differ. 2012;19:1750&#x2013;1760. doi: 10.1038/cdd.2012.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2012.56</ArticleId><ArticleId IdType="pmc">PMC3469086</ArticleId><ArticleId IdType="pubmed">22555458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, et al. MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI (3) K pathway. Nat. Cell Biol. 2013;15:1153&#x2013;1163. doi: 10.1038/ncb2827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2827</ArticleId><ArticleId IdType="pmc">PMC3789848</ArticleId><ArticleId IdType="pubmed">23974039</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, et al. MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2. FASEB J. 2010;24:3950. doi: 10.1096/fj.10-157404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-157404</ArticleId><ArticleId IdType="pmc">PMC2996908</ArticleId><ArticleId IdType="pubmed">20530248</ArticleId></ArticleIdList></Reference><Reference><Citation>Nateghi B, Emadi F, Eghbali M, Pezeshki P, Eshaghiyan A. Circulating miR-193b-3p and miR-376a-3p involved in Iranian patients with multiple sclerosis. Int. Biol. Biomed. J. 2019;5:24&#x2013;28.</Citation></Reference><Reference><Citation>Wang Y, et al. Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axis. Int. J. Biol. Sci. 2022;18:1491. doi: 10.7150/ijbs.69351.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.69351</ArticleId><ArticleId IdType="pmc">PMC8898370</ArticleId><ArticleId IdType="pubmed">35280687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau P, Frigerio CS, De Strooper B. Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: The need of larger datasets. Ageing Res. Rev. 2014;17:43&#x2013;53. doi: 10.1016/j.arr.2014.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2014.02.006</ArticleId><ArticleId IdType="pubmed">24607832</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y, et al. Exploration of alcohol use disorder-associated brain miRNA&#x2013;mRNA regulatory networks. Transl. Psychiatry. 2021;11:504. doi: 10.1038/s41398-021-01635-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01635-w</ArticleId><ArticleId IdType="pmc">PMC8487426</ArticleId><ArticleId IdType="pubmed">34601489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Reddy PH. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2016;1862:1617&#x2013;1627. doi: 10.1016/j.bbadis.2016.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.06.001</ArticleId><ArticleId IdType="pmc">PMC5343750</ArticleId><ArticleId IdType="pubmed">27264337</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalsky RL, et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 2012;8:e1002484. doi: 10.1371/journal.ppat.1002484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002484</ArticleId><ArticleId IdType="pmc">PMC3266933</ArticleId><ArticleId IdType="pubmed">22291592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer. 2002;2:647&#x2013;656. doi: 10.1038/nrc883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc883</ArticleId><ArticleId IdType="pubmed">12209154</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar, R. S., Ness, J. M. &amp; Roth, K. A. Bcl-2 family regulation of neuronal development and neurodegeneration. Biochim. Biophys. Acta (BBA)-Mol. Cell Res.1644, 189&#x2013;203 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14996503</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu X, He J, Anderson DW, Springer JE, Trojanowski JQ. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 1996;40:379&#x2013;386. doi: 10.1002/ana.410400307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410400307</ArticleId><ArticleId IdType="pubmed">8797527</ArticleId></ArticleIdList></Reference><Reference><Citation>Troost, D., Aten, J., Morsink, F. &amp; De Jong, J. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl&#x2010;2 expression is increased in unaffected post&#x2010;central gyrus. Neuropathol. Appl. Neurobiol.21, 498&#x2013;504 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8745239</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 1997;277:559&#x2013;563. doi: 10.1126/science.277.5325.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.277.5325.559</ArticleId><ArticleId IdType="pubmed">9228005</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M, et al. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2. Hum. Mol. Genet. 2000;9:803&#x2013;811. doi: 10.1093/hmg/9.5.803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.5.803</ArticleId><ArticleId IdType="pubmed">10749988</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrini S, et al. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum. Mol. Genet. 2010;19:2974&#x2013;2986. doi: 10.1093/hmg/ddq202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq202</ArticleId><ArticleId IdType="pmc">PMC2901139</ArticleId><ArticleId IdType="pubmed">20460269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lees J, Shneidman P, Skuntz S, Carden M, Lazzarini R. The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO J. 1988;7:1947&#x2013;1955. doi: 10.1002/j.1460-2075.1988.tb03032.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1988.tb03032.x</ArticleId><ArticleId IdType="pmc">PMC454466</ArticleId><ArticleId IdType="pubmed">3138108</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, H., Zhao, Y., Caramuta, S., Larsson, C. &amp; Lui, W.-O. miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells. (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3463520</ArticleId><ArticleId IdType="pubmed">23056551</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki T, et al. In vivo and in vitro phosphorylation at Ser-493 in the glutamate (E)-segment of neurofilament-H subunit by glycogen synthase kinase 3&#x3b2;. J. Biol. Chem. 2002;277:36032&#x2013;36039. doi: 10.1074/jbc.M206674200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M206674200</ArticleId><ArticleId IdType="pubmed">12130654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, et al. Neurofilament heavy polypeptide regulates the Akt-&#x3b2;-catenin pathway in human esophageal squamous cell carcinoma. PLoS ONE. 2010;5:e9003. doi: 10.1371/journal.pone.0009003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009003</ArticleId><ArticleId IdType="pmc">PMC2815775</ArticleId><ArticleId IdType="pubmed">20140245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, et al. Sequencing of neurofilament genes identified NEFH Ser787Arg as a novel risk variant of sporadic amyotrophic lateral sclerosis in Chinese subjects. BMC Med. Genomics. 2021;14:1&#x2013;8. doi: 10.1186/s12920-021-01073-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-021-01073-z</ArticleId><ArticleId IdType="pmc">PMC8436554</ArticleId><ArticleId IdType="pubmed">34511133</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F, et al. Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset. Sci. Rep.-UK. 2022;12:14739. doi: 10.1038/s41598-022-18942-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18942-x</ArticleId><ArticleId IdType="pmc">PMC9427846</ArticleId><ArticleId IdType="pubmed">36042248</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D, Hawley ZC, Strong MJ. Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs. Mol. Brain. 2018;11:1&#x2013;9. doi: 10.1186/s13041-018-0386-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-018-0386-3</ArticleId><ArticleId IdType="pmc">PMC6054723</ArticleId><ArticleId IdType="pubmed">30029677</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinacho R, et al. Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2016;177:88&#x2013;97. doi: 10.1016/j.schres.2016.04.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2016.04.050</ArticleId><ArticleId IdType="pubmed">27236410</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto K, et al. Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci. Res. 2004;49:379&#x2013;385. doi: 10.1016/j.neures.2004.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2004.04.002</ArticleId><ArticleId IdType="pubmed">15236863</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J, et al. A novel missense pathogenic variant in NEFH causing rare Charcot-Marie-Tooth neuropathy type 2CC. Neurol. Sci. 2021;42:757&#x2013;763. doi: 10.1007/s10072-020-04595-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04595-z</ArticleId><ArticleId IdType="pubmed">32780247</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y, et al. Emerging views of OPTN (optineurin) function in the autophagic process associated with disease. Autophagy. 2022;18:73&#x2013;85. doi: 10.1080/15548627.2021.1908722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1908722</ArticleId><ArticleId IdType="pmc">PMC8865304</ArticleId><ArticleId IdType="pubmed">33783320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228&#x2013;233. doi: 10.1126/science.1205405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205405</ArticleId><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying H, Yue BY. Optineurin: The autophagy connection. Exp. Eye Res. 2016;144:73&#x2013;80. doi: 10.1016/j.exer.2015.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2015.06.029</ArticleId><ArticleId IdType="pmc">PMC4698099</ArticleId><ArticleId IdType="pubmed">26142952</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X, et al. Processing of optineurin in neuronal cells. J. Biol. Chem. 2011;286:3618&#x2013;3629. doi: 10.1074/jbc.M110.175810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.175810</ArticleId><ArticleId IdType="pmc">PMC3030366</ArticleId><ArticleId IdType="pubmed">21059646</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano K, et al. Critical role of mitochondrial ubiquitination and the OPTN&#x2013;ATG9A axis in mitophagy. J. Cell Biol. 2020;219:12144. doi: 10.1083/jcb.201912144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201912144</ArticleId><ArticleId IdType="pmc">PMC7480101</ArticleId><ArticleId IdType="pubmed">32556086</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawa-Makarska J, et al. Reconstitution of autophagosome nucleation defines Atg9 vesicles as seeds for membrane formation. Science. 2020;369:eaaz7714. doi: 10.1126/science.aaz7714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz7714</ArticleId><ArticleId IdType="pmc">PMC7610778</ArticleId><ArticleId IdType="pubmed">32883836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V, et al. Sorting rare ALS genetic variants by targeted re-sequencing panel in Italian patients: OPTN, VCP, and SQSTM1 variants account for 3% of rare genetic forms. J. Clin. Med. 2020;9:412. doi: 10.3390/jcm9020412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020412</ArticleId><ArticleId IdType="pmc">PMC7073901</ArticleId><ArticleId IdType="pubmed">32028661</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, et al. A familial amyotrophic lateral sclerosis pedigree discordant for a novel p. Glu46Asp heterozygous OPTN variant and the p. Ala5Val heterozygous SOD1 missense mutation. J. Clin. Neurosci. 2020;75:223&#x2013;225. doi: 10.1016/j.jocn.2020.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.03.032</ArticleId><ArticleId IdType="pubmed">32223976</ArticleId></ArticleIdList></Reference><Reference><Citation>Mou Y, et al. OPTN variants in ALS cases: A case report of a novel mutation and literature review. Neurol. Sci. 2022;43:5391&#x2013;5396. doi: 10.1007/s10072-022-06125-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06125-5</ArticleId><ArticleId IdType="pubmed">35661277</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans CS, Holzbaur EL. Lysosomal degradation of depolarized mitochondria is rate-limiting in OPTN-dependent neuronal mitophagy. Autophagy. 2020;16:962&#x2013;964. doi: 10.1080/15548627.2020.1734330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1734330</ArticleId><ArticleId IdType="pmc">PMC7144876</ArticleId><ArticleId IdType="pubmed">32131674</ArticleId></ArticleIdList></Reference><Reference><Citation>Medchalmi S, Tare P, Sayyad Z, Swarup G. A glaucoma-and ALS-associated mutant of OPTN induces neuronal cell death dependent on Tbk1 activity, autophagy and ER stress. FEBS J. 2021;288:4576&#x2013;4595. doi: 10.1111/febs.15752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15752</ArticleId><ArticleId IdType="pubmed">33548116</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman, M., Benatar, M., Lavi, E. S., Latchman, K. &amp; Singer, C. (AAN Enterprises, 2023).</Citation></Reference><Reference><Citation>Wang C, et al. Isoforsythiaside attenuates Alzheimer&#x2019;s disease via regulating mitochondrial function through the PI3K/AKT pathway. Int. J. Mol. Sci. 2020;21:5687. doi: 10.3390/ijms21165687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165687</ArticleId><ArticleId IdType="pmc">PMC7460834</ArticleId><ArticleId IdType="pubmed">32784451</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, et al. AMP-activated protein kinase-dependent autophagy mediated the protective effect of sonic hedgehog pathway on oxygen glucose deprivation-induced injury of cardiomyocytes. Biochem. Biophys. Res. Commun. 2015;457:419&#x2013;425. doi: 10.1016/j.bbrc.2015.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.01.006</ArticleId><ArticleId IdType="pubmed">25582777</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, et al. Downregulated AEG-1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model. Mol. Cell. Neurosci. 2015;68:303&#x2013;313. doi: 10.1016/j.mcn.2015.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.08.009</ArticleId><ArticleId IdType="pubmed">26320681</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>